Jul 20, 2017
Julie is an executive pharmaceutical leader with over 20 years
of experience across all phases of development both on the
commercial and research sides of the organization. She leverages
her Masters in Business Administration and Doctorate of Pharmacy to
develop and deliver strategic patient-centric value propositions to
optimize patient access and improve outcomes in patients with
difficult to treat diseases leading to longer, healthier, and more
productive lives. Her years of experience in global and US payer
markets provides Julie with intimate knowledge of the current and
evolving payer and market access landscape in the US and around the
globe. She has led the development and execution of several
outcomes-based contracts with 3 of the largest national payer
organizations in the US.
Dr. Locklear is well published, having authored >30 publications
in peer-reviewed journals and >60 peer-reviewed abstracts
presented as posters at major scientific congresses.